BRUSSELS, June 3 (Reuters) - U.S. disease diagnosis firm Gen-Probe Inc launched a 215 million euro ($335.4 million) counterbid for Belgian peer Innogenetics NV on Tuesday, trumping an offer from local ...
Enterome developed GeneMark-HM software in collaboration with Gene Probe Inc. PARIS, June 16, 2021 /PRNewswire/ -- ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based ...
Gen-Probe Inc. (NSDQ:GPRO) bought Waukesha, Wis.-based GTI Diagnostics in a self-funded $53 million cash deal. The acquisition allows the San Diego-based company to expand its transplant diagnostics ...
LOS ANGELES, July 31 (Reuters) - Gen-Probe Inc Inc said on Thursday its second-quarter net income fell 8 percent as record sales of clinical diagnostics products and blood screening tests failed to ...
Firm has molecular tests for respiratory infectious diseases. Gen-Probe plans on acquiring Prodesse for approximately $60 million in cash. Achievement of certain financial and regulatory milestones in ...
Diagnostic products maker Gen-Probe Inc. (:GPRO) has secured the approval of the U.S. Food and Drug Administration ("FDA") for its PROGENSA PCA3 assay, a novel molecular test designed to aid the ...
Background and objectives: The nonisotopic DNA probe assay (PACE 2) was evaluated for the detection of Neisseria gonorrhoeae in urethral and endocervical specimens and compared quantitatively and ...
In November, President Bush named in vitro diagnostics manufacturer Gen-Probe Inc. (San Diego) as one of seven National Medal of Technology laureates for 2004. The company was recognized for the ...
announced today that the Company has acquired GTI Diagnostics, a privately held specialty diagnostics company focused on the transplantation, blood bank and specialty coagulation markets, for $53 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback